Accessibility Menu
 
Diaceutics Plc logo

Diaceutics Plc

(LSE) DXRX

Current Price$165.00
Market Cap$14.00B
Since IPO (2019)+73%
5 Year+32%
1 Year+36%
1 Month+6%

Diaceutics Plc Financials at a Glance

Market Cap

$14.00B

Revenue (TTM)

$60.50M

Net Income (TTM)

$4.37M

EPS (TTM)

$-1.80

P/E Ratio

-91.94

Dividend

$0.00

Beta (Volatility)

-0.04 (Low)

Price

$165.00

Volume

20,545

Open

$165.50

Previous Close

$165.00

Daily Range

$165.00 - $165.50

52-Week Range

$112.25 - $177.00

DXRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Diaceutics Plc

Industry

Life Sciences Tools and Services

Employees

199

CEO

Ryan Gerard Keeling

Headquarters

Belfast, BT9 6GW, GB

DXRX Financials

Key Financial Metrics (TTM)

Gross Margin

86%

Operating Margin

-6%

Net Income Margin

-4%

Return on Equity

-4%

Return on Capital

-6%

Return on Assets

-3%

Earnings Yield

-1.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.00B

Shares Outstanding

84.59M

Volume

20.55K

Avg. Volume

130.14K

Financials (TTM)

Gross Profit

$28.27M

Operating Income

$2.46M

EBITDA

$2.77M

Operating Cash Flow

$651.00K

Capital Expenditure

$4.63M

Free Cash Flow

$3.98M

Cash & ST Invst.

$12.74M

Total Debt

$1.06M

Diaceutics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$14.56M

+46.8%

Gross Profit

$12.09M

+74.5%

Gross Margin

82.99%

N/A

Market Cap

$14.00B

N/A

Market Cap/Employee

$76.09M

N/A

Employees

184

N/A

Net Income

$2.40M

-61.7%

EBITDA

$1.34M

-6805.0%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$9.25M

-44.3%

Accounts Receivable

$11.37M

N/A

Inventory

$0.00

N/A

Long Term Debt

$905.00K

-20.1%

Short Term Debt

$458.00K

+257.8%

Return on Assets

-3.42%

N/A

Return on Invested Capital

-5.80%

N/A

Free Cash Flow

$550.00K

+127.6%

Operating Cash Flow

$605.00K

-36.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANCR.LAnimalcare Group plc
$332.50+0.15%
TSTL.LTristel PLC
$405.00+3.32%
BXP.LBeximco Pharmaceuticals Limited
$42.50+0.00%
OPT.LOptima Health plc
$188.50+1.07%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About DXRX

What is the current price of Diaceutics Plc?

Diaceutics Plc is trading at GBX 165.00 per share.

What is the 52-week range for Diaceutics Plc?

Over the past 52 weeks, Diaceutics Plc has traded between GBX 112.25 and GBX 177.00.

How much debt does Diaceutics Plc have?

As of the most recent reporting period, Diaceutics Plc reported total debt of $1.06M.

How much cash does Diaceutics Plc have on hand?

Diaceutics Plc reported $12.74M in cash and cash equivalents in its most recent financial results.

What is Diaceutics Plc’s dividend yield?

Diaceutics Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.